Emcure Pharmaceuticals Partners With Sunsure Energy For 22.78 MWp Solar Power, Boosting Sustainability Efforts

Emcure Pharmaceuticals, an Indian pharmaceutical company with a diversified product portfolio, signed a  22.78 MWp DC Solar Power Purchase Agreement (PPA) with Sunsure Energy, a prominent renewable power producer in India. 

The company in a press statement on Friday said that the partnership will provide Emcure and its subsidiary, Gennova Biopharmaceuticals, with approximately 36 million units of clean, renewable energy annually for their Pune plants. This initiative is expected to meet around 67 per cent of the power requirements for these plants with green energy, offsetting 29,765.71 metric tons of CO2 annually.

In addition to the PPA, Emcure and Gennova have signed a Shareholders Agreement to acquire a stake in Sunsure Solarpark Twelve , facilitating the purchase of solar power under a group captive scheme as per the Electricity Act, 2023, and applicable rules.

The agreement with Sunsure Energy, which will supply power from its 150 MWp DC solar plant in Solapur, Maharashtra, is a significant step forward in Emcure’s commitment to integrating sustainability into its operations and minimising its environmental impact.

Sunil Mehta, Whole-time Director of Emcure Pharmaceuticals, commented: "At Emcure, we are dedicated not only to improving lives through innovation and research for our differentiated portfolio but also through efficient and environment-friendly manufacturing processes. Our partnership with Sunsure Energy is a testament to promoting innovative solutions in the pharmaceutical industry to reduce the industry’s carbon footprint by embracing the power of renewable energy. Emcure is proud to be leading the adoption of solar power in the pharmaceutical industry in India. We look forward to continuing our collaboration with Sunsure Energy to achieve new milestones in our green energy journey."

Shashank Sharma, Founder and CEO of Sunsure Energy, remarked, "We are thrilled to onboard Emcure Pharmaceuticals, a global leader in the pharmaceutical industry, to our esteemed family of customers. This PPA demonstrates Sunsure’s dedication to facilitating the renewable energy transition for leading corporations in the pharmaceutical sector. By working together, we are not only powering Emcure's facilities with clean energy but also driving broader environmental stewardship within the industry."